LW · NYSE · STOCK
Lamb Weston Holdings (LW) Stock Analysis
$47.88
52W $37.62 – $67.07
49/100
$6.58B
25.9
0.47
Is LW Bullish or Bearish?
Mixed.
Innellis AI committee rates Lamb Weston Holdings, Inc. (LW) Watch with a composite score of 49/100
, based on 6 analysts with 67% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +10.82 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -9.18 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 26.1 is moderate-to-rich — Value
- Debt-to-equity of 2.15 adds balance-sheet risk to the value case — Value
- EPS declining -11.7% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Price structure making lower highs and lower lows — Technical
- Price structure (HH_HL) contradicts the downtrend -- mixed signals — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
49/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 88%
of 72 Consumer Defensive peers
Value Analyst
neutral
43
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 26.1 is moderate-to-rich
Growth Analyst
neutral
44
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 5 consecutive earnings beats -- consistent execution
− EPS declining -11.7% YoY despite any revenue growth
Technical Analyst
neutral
53
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 2.15) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 50.3 to 49.2.
- New bearish signals: 2 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- Bearish pressure eased: 2 signal(s) disappeared.
Analyst-level changes:
- Growth Analyst: +1 bearish signal(s).
- Technical Analyst: score 47->53 (+6).
- Value Analyst: score 56->43 (-13); +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
60.0
Neutral
MACD Histogram
0.770
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Hh Hl
Support
$40.19
Resistance
$51.94
Bollinger %B
0.73
Inside Bands
Price vs Moving Averages
EMA 9
$46.52
Above
EMA 21
$46.61
Above
EMA 50
$47.80
Above
EMA 200
$48.26
Below
Fundamental Analysis
Valuation
74
Growth
56
Profitability
34
Financial Health
35
Cash Flow
70
Valuation
P/E Ratio
25.9×
P/B Ratio
3.65×
PEG Ratio
-2.25
Dividend Yield
3.15%
52W High
$67.07
52W Low
$37.62
Quality & Growth
ROE
1589.1%
ROA
392.9%
Gross Margin
1938.3%
Operating Margin
780.3%
Revenue Growth YoY
—
Debt / Equity
2.17
AI Fundamental Assessment
P/E ratio of 25.9 (moderate relative to a 15-40x range); Price-to-book of 3.6x; PEG ratio of -2.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 15.9%; Return on assets of 3.9%; Net margin of 3.8%; Gross margin of 19.4%; Current ratio of 1.45 (tight short-term liquidity); Debt-to-equity of 2.17; Free cash flow per share is positive (3.70); Most recent quarter beat estimates by 23.8%; 5 consecutive earnings beats; EPS growth decelerating (+20.8% -> -13.8% QoQ); Average YoY EPS growth of 1.4%; Analyst estimates falling over recent quarters
Get the Full LW Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →